Hormone-Refractory Prostate Cancer: What to Know

You may also hear this condition called castration-resistant prostate cancer. It does not mean that hormone treatment has failed in every way or that no treatment remains. It means that some prostate cancer cells can continue using signals that support growth, or can adapt when those signals are reduced. The cancer may be confined to the prostate area or may have spread to other parts of the body, including bones. Your clinician assesses this using symptoms, physical examination, prostate-specific antigen testing, hormone levels, and imaging when appropriate.

A changing test result alone does not describe the whole situation. The pattern over time, scan findings, previous treatment, general health, and your priorities all help shape the next decision.

Keep taking prescribed hormone therapy unless your oncology team tells you to stop, and attend planned blood tests or scans. Ask which findings show that the cancer is changing and when results will be reviewed. Treatment may involve changing or adding medicines that act on hormone signalling, chemotherapy, radiotherapy, or a targeted radioisotope treatment. If cancer affects the bones, a bone-strengthening treatment and a plan for pain, movement, and fall prevention may be considered. Decisions depend on where the cancer is, your earlier treatments, side effects, and other health conditions.

Tell the team about new pain, tiredness, appetite changes, numbness, or difficulty with daily activities. A written list of medicines and supplements can help the team check for interactions and manage side effects.

Contact your oncology team promptly about new or worsening bone or back pain, especially if it limits walking or sleep. Seek urgent medical help for new leg weakness, numbness around the groin, loss of bladder or bowel control, or inability to pass urine. These symptoms can signal pressure on nerves or a urinary blockage and need rapid assessment. Fever or feeling suddenly unwell during cancer treatment also warrants prompt advice because treatment can affect the body’s ability to respond to infection.

You could ask: What shows that my cancer is hormone-refractory? Is it still in the prostate area, or has it spread? Which tests do I need, and what will each test tell us? What treatment choices fit my previous care and health? What side effects should I report straight away? How can we protect my bones and manage pain or urinary symptoms? Who should I contact outside clinic hours?